Explore our growing portfolio of quality-focused pharmaceutical products, carefully selected to support important therapeutic needs and contribute to better healthcare outcomes.

KOEN™
Coenzyme Q10 100 mg + L-Carnitine 500 mg
TABLETS
FOR NEPHROLOGY SEGMENT
ENERGY. PROTECTION. PERFORMANCE.
FOR BETTER RENAL OUTCOMES.
SCHEDULE H DRUG
Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
DUAL ACTION FORMULA
Coenzyme Q10
Powerful antioxidant
Improves mitochondrial energy production
Helps reduce oxidative stress
Supports overall cellular function
L-Carnitine
Supports fatty acid transport & energy metabolism
Helps improve protein-energy status
Supports muscle & cardiac function
Improves dialysis tolerance
SUPPORTS IN
Improves Renal Energy
Increases Iron Absorption by Decreasing Hepcidin
Increases HDL Level
Decreases Triglycerides
Reduces Oxidative Stress & Inflammation
Improves Overall Patient Outcomes
USEFUL IN
CKD (Pre-dialysis & Dialysis)
Anemia of CKD
ESA Hyporesponsiveness
Hypertriglyceridemia
Dyslipidemia in CKD
Protein Energy Wasting
Fatigue & Low Exercise Tolerance
High Quality Ingredients | Scientifically Formulated | Renal Focused Care |
For Cardiology Segments use: KOEN™
Coenzyme Q10 100 mg + L-Carnitine 500 mg Tablets
Cardiac Energy & Antioxidant Support
A dual-action formulation designed to support myocardial energy metabolism, antioxidant defence and overall cardiovascular function.
Key Benefits
Supports myocardial energy production
Helps reduce oxidative stress
Supports cardiac function
Supports exercise capacity
Promotes overall cardiovascular health
Composition: Coenzyme Q10 100 mg + L-Carnitine 500 mg
Dosage: As directed by the physician.
Schedule H Drug – For use under medical supervision.

KONVEL 400 Sevelamer Carbonate 400 mg Tablets PHOSPHATE CONTROL IN CKD-MBD Non-Calcium • Non-Metal Phosphate Binder KEY BENEFITS Effective Phosphate Binding Binds dietary phosphate in the gut to reduce serum phosphorus levels. Supports Bone Health Helps in the management of hyperphosphatemia in CKD. Cardiovascular Protection May help reduce the risk of vascular calcification associated with CKD. Gut Retentive | Non-Calcium Binder Well tolerated with minimal systemic absorption. FOR PATIENTS WITH HYPERPHOSPHATEMIA CKD Patients with persistently elevated serum phosphorus (Pre-dialysis) Hemodialysis Patients KONVEL 400 – TRUSTED PARTNER IN PHOSPHORUS MANAGEMENT
Koncure Pharma Pvt. Ltd. is committed to building meaningful and long-term relationships with healthcare professionals and business partners.
Koncure Pharma Pvt. Ltd. is a quality-focused pharmaceutical company committed to delivering responsible healthcare solutions
All rights reserved @ 2026 Handcrafted By itinfoways.com